Home/Filings/4/0001415889-22-011523
4//SEC Filing

GRAHAM RICHARD A 4

Accession 0001415889-22-011523

CIK 0001583107other

Filed

Nov 16, 7:00 PM ET

Accepted

Nov 17, 7:53 PM ET

Size

4.5 KB

Accession

0001415889-22-011523

Insider Transaction Report

Form 4
Period: 2022-11-16
GRAHAM RICHARD A
SVP, Development
Transactions
  • Tax Payment

    Ordinary Shares

    2022-11-16$11.20/sh2,800$31,360342,954 total

Issuer

Theravance Biopharma, Inc.

CIK 0001583107

Entity typeother

Related Parties

1
  • filerCIK 0001820036

Filing Metadata

Form type
4
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 7:53 PM ET
Size
4.5 KB